NANX Nanophase Technologies Corp.

Solésence Beauty Science Wins Cosmopack North America Formulation Award, Announces New Market-Ready Products in Lip Category

Solésence Beauty Science Wins Cosmopack North America Formulation Award, Announces New Market-Ready Products in Lip Category

ROMEOVILLE, Ill., Aug. 16, 2022 (GLOBE NEWSWIRE) -- Solésence Beauty Science, a leader in inclusive, mineral-based beauty products for skincare and makeup brands, and a wholly owned subsidiary of Nanophase Technologies, today announced that their market-ready product, Multi-Cultural Magic SPF 50+ featuring Kleair™, was named as the winner of the prestigious Cosmopack Award for Formulation. The Company has also debuted two new market-ready products focused on innovation in the skin and sun sector, across makeup and skin care categories.

The winning formula, Multi-Cultural Magic SPF 50+ featuring Kleair™, was envisioned to create a clean, inclusive, mineral-based UV protection skincare product that is a pleasure to use. Using the unique benefits of Kleair™, a proprietary technology that is available only through Solésence products, unlocks a suite of skin health benefits — from broad-spectrum, mineral-based, and non-nano UV protection to free radical prevention — while also demonstrating moisturization benefits. The formula, which was specifically designed with all skin tones in mind, leaves skin feeling smooth and moisturized, while extremely high-transparency zinc oxide reduces the signs of early aging, such as fine lines, blotchiness, and an uneven skin appearance.

The Cosmoprof North America Awards and Cosmopack North America Awards “formally recognize the absolute best in beauty products, celebrate innovation, and honor excellence in packaging design and formulation,” according to the Awards . It is “a one-of-a-kind celebration honoring the trailblazers and risk-takers breaking away from the beauty status quo.” The Cosmopack North America Awards in particular bring “awareness to the immense value that lies in the formulation, technology and packaging design and take in special consideration the new technologies that lie underneath our beauty industries.”

The Formulation category, which included makeup, skincare and all other cosmetics categories, had been narrowed to four finalists on June 20, 2022, based upon each submission’s perceived innovation, marketability, technology, quality and overall sustainability. The winners were then announced after a live jury panel assessed the final four finished formulas at Cosmoprof in Las Vegas.

The win comes alongside the launch of two additions to the Solésence market-ready products menu: and . Each of these white label products for brands leverages the Kleair™ technology to achieve elegant, mineral-based skin health formulas in makeup and skin care, respectively. In each product, the innovation-driven approach incorporates the latest trends while tapping into market drivers across beauty and personal care, including convenience, multi-functional skin heroes, and skin health.

About Solésence Beauty Science   

Solésence, LLC, , a wholly owned subsidiary of Nanophase Technologies, is changing the face of skin health with patented, mineral-based technology that is embraced by leading performance-driven and clean beauty brands alike. Our patented products for brands transform the way mineral actives look, feel and function — enabling textures never-before-seen in the mineral space and inclusivity never-before-seen in the sun care space. Solésence’s innovative formulations offer best-in-class UV protection, unparalleled free radical prevention to protect against pollution, and enhanced antioxidant performance.

About Nanophase Technologies    

Nanophase Technologies Corporation (OTCQB: NANX), , is a leading innovator in minerals-based and scientifically driven health care solutions across beauty and life science categories, as well as other legacy advanced materials applications. Leveraging a platform of integrated, patented, and proprietary technologies, the Company creates products with unique performance, enhancing consumers' health and wellbeing. We deliver commercial quantity and quality engineered materials both as ingredients and as part of fully formulated products in a variety of formats.    

Forward-Looking Statements  

This press release contains words such as “expects,” shall,” “will,” “believes,” and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company’s current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company’s results of operations, performance, and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company’s dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company’s engineered materials, ingredients, and fully formulated products; the Company’s manufacturing capacity and product mix flexibility in light of customer demand; the Company’s limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company’s dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; the impact of any potential new government regulations that could be difficult to respond to or too costly to comply with while remaining financially viable; the ability of the Company to maintain an appropriate electronic trading venue; and other factors described in the Company’s Form 10-K filed March 31, 2022. In addition, the Company’s forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties, or other contingencies.

Media Contact:

Emma Harper

Email:

Phone: (630) 686-1574

Investor Relations Contact:

Phone: (630) 771-6736

 



EN
16/08/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nanophase Technologies Corp.

 PRESS RELEASE

Solésence Reports Record First Quarter 2025 Financial Results

Solésence Reports Record First Quarter 2025 Financial Results First quarter revenue increased 48% to a record $14.6 million ROMEOVILLE, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the first quarter ended March 31, 2025.    Recent Highlights and Accomplishments Uplisted to Nasdaq under the ticker “SLSN” supporting the Company’s increased visibility with the investment communityAchieved record revenue and unit volume shipments...

 PRESS RELEASE

Solésence To Report First Quarter 2025 Financial Results and Host a Co...

Solésence To Report First Quarter 2025 Financial Results and Host a Conference Call ROMEOVILLE, Ill., April 28, 2025 (GLOBE NEWSWIRE) -- Romeoville, Ill., April 28, 2025 – Solésence, Inc. (Nasdaq: SLSN), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the first quarter of 2025 after the market close on Monday, May 5, 2025, and host a conference call and webcast on the same date. First Quarter 2025 Conference Call Details Date / Time: Monday, May 5, 2025 - 4:00 p.m. CDT, 5:00 p.m. ...

 PRESS RELEASE

Solésence Announces Uplisting to Nasdaq

Solésence Announces Uplisting to Nasdaq Trading set to begin Tuesday, April 8 under new ticker “SLSN” ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has received approval from the Listing Qualifications Department of Nasdaq to transfer its listing to the Nasdaq Capital Market. The Company’s securities will be uplisted to Nasdaq at the opening of business on Tuesday, April 8, 2025. Prior to listing on Nasdaq, the Company’s shares t...

 PRESS RELEASE

Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial R...

Solésence Reports Record Fourth Quarter and Full-Year 2024 Financial Results Fourth quarter revenue increased 58% to a record $12.6 million Full Year 2024 revenue increased 40% to a record $52.3 million ROMEOVILLE, Ill., March 26, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced financial results for the fourth quarter and year ended December 31, 2024.    Recent Highlights and Accomplishments Company rebranded as Solésence, Inc., marking a new era of innovation, se...

 PRESS RELEASE

Solésence To Report Fourth Quarter and Full Year 2024 Financial Result...

Solésence To Report Fourth Quarter and Full Year 2024 Financial Results and Host a Conference Call ROMEOVILLE, Ill., March 20, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that the Company will report results for the fourth quarter and full year 2024 after the market close on Wednesday, March 26, 2025, and host a conference call and webcast on Thursday, March 27. Fourth Quarter 2024 Conference Call Details Date / Time: Thursday, March 27, 2025 - 7:00 a.m. CDT, 8:...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch